Oxcarbazepine Tablet, Film Coated
Product Images NDC 82804-209

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 82804-209). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

82804-209-72 (Image 01)

Label for Oxcarbazepine 300 mg film-coated tablets by Proficient Rx LP. The label indicates a quantity of 120 tablets, with instructions to dispense a Medication Guide separately. Tablets are described as brown, oval, biconvex with specific debossed markings. Manufactured by Annora Pharma Pvt. Ltd., India. Storage temperature range included. NDC 82804-209-72 is shown.*

FDA Label Image

Oxcarbazepinetabfig1 (Oxcarbazepinetabfig1)

A survival analysis plot depicting exit rates over time on trial from Day 2 to Day 11. The chart compares two treatment groups: Oxcarbazepine, represented by a solid line, and Placebo, shown as a dashed line. The exit rate for the placebo group increases more rapidly compared to Oxcarbazepine. A log-rank test with p-value of 0.0001 is noted on the graph.*

FDA Label Image

Oxcarbazepinetabfig2 (Oxcarbazepinetabfig2)

A Kaplan-Meier curve chart depicting the seizure rate over time (days from first dose to first seizure) comparing treatment groups. The chart shows seizure rates for Oxcarbazepine versus Placebo, with a log-rank test p-value of 0.046 indicating statistical comparison.*

FDA Label Image

Oxcarbazepinetabfig3 (Oxcarbazepinetabfig3)

A Kaplan-Meier survival curve chart showing exit rate over time in days, comparing two treatment groups labeled HIGH and LOW. The X-axis represents time to exit in days (0 to 130), and the Y-axis shows the exit rate (0.0 to 1.0). The HIGH group is depicted with a solid line, and the LOW group with a dotted line. A log-rank test p-value of 0.0001 is noted on the chart.*

FDA Label Image

Oxcarbazepinetabfig4 (Oxcarbazepinetabfig4)

A Kaplan-Meier survival curve chart displaying exit rates over time in days for two treatment groups labeled HIGH and LOW. The y-axis shows exit rate from 0.0 to 1.0, and the x-axis shows time to exit from 0 to 130 days. The LOW group has a higher and faster exit rate than the HIGH group. A log-rank test with a p-value of 0.0001 is noted in the chart.*

FDA Label Image

Oxcarbazepinetabstruct (Oxcarbazepinetabstruct)

Chemical structure diagram of oxcarbazepine showing its molecular framework with a central nitrogen atom, two carbonyl groups, and fused aromatic rings.*

FDA Label Image

Oxcarbazipinetabcamberlogo1 (Oxcarbazipinetabcamberlogo1)

FDA Label Image

Oxcarbazipinetabcamberlogo2 (Oxcarbazipinetabcamberlogo2)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.